Skip to main content
Premium Trial:

Request an Annual Quote

Biosearch Licenses IP to DuPont for Food Dx Development

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DuPont Qualicon will have access to Biosearch Technologies' BHQ, CAL Fluor, and Quasar patents under a licensing agreement announced today.

As part of the deal, Biosearch will also manufacture Scorpions primer oligonucleotides for use in food diagnostics by DuPont. This past summer, Biosearch signed an agreement with Qiagen, expanding its rights to the Scorpions primer technology.

Financial terms of the alliance with DuPont were not disclosed.

Biosearch last week entered into a licensing deal with Seegene also covering the BHQ, CAL Fluor, and Quasar technologies.

In a statement announcing today's deal, Marc Beal, director of corporate development for Biosearch, said that it and DuPont's capabilities would deliver "an innovative and exacting molecular diagnostics solution," and added that the company looks forward to working with DuPont as it commercializes BHQ Scorpions-based foodborne pathogen diagnostics.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more